maintenance of bone health has been a clinical challenge in breast malignancy individuals receiving adjuvant endocrine treatment. demonstrated a significant increase of 5.5% in bone mineral density (BMD) in K252a the lumbar spine with denosumab in 252 women with non-metastatic breast cancer receiving aromatase inhibitors 2 this trial was not designed to assess fracture risk.… Continue reading maintenance of bone health has been a clinical challenge in breast